{"id":49472,"date":"2022-10-11T12:01:55","date_gmt":"2022-10-11T10:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/"},"modified":"2022-10-11T12:01:55","modified_gmt":"2022-10-11T10:01:55","slug":"compass-personalized-spine-surgery-study-begins-enrollment","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/","title":{"rendered":"COMPaSS\u2122 Personalized Spine Surgery Study Begins Enrollment"},"content":{"rendered":"
\n

CARLSBAD, Calif.–(BUSINESS WIRE)–#NASS<\/a>–Carlsmed\u00ae<\/span><\/sup> announced today that the first patients have been enrolled in the COMPaSS\u2122 study. COMPaSS, C<\/span>linical O<\/span>utcome M<\/span>easures in P<\/span>ersonalized a<\/span>prevo\u00ae<\/sup> S<\/span>pine S<\/span>urgery, is a multi-center post market prospective observational registry. The study will collect data on patients with degenerative spinal conditions and are treated surgically with Carlsmed aprevo devices and will track outcomes for a period of two years.\n<\/p>\n

<\/a><\/p>\n

\n\u201cThe COMPaSS study will generate first-of-its-kind preoperative intervertebral data for surgical planning and personalized aprevo designs along with postoperative metrics for spinal alignment and clinical outcomes,\u201d commented Roland Kent, MD, the COMPaSS study Chief Investigator. \u201cAfter observing excellent initial results with aprevo in my own patients, I am excited to collaborate with colleagues across the country to verify durability of achieved spinal alignment and assess patient satisfaction over the next two years.\u201d\n<\/p>\n

\n\u201cThe COMPaSS study further advances Carlsmed\u2019s mission to collect data and improve outcomes of patients through the power of personalized spine surgery,\u201d stated Mike Cordonnier, CEO of Carlsmed. \u201cThe ongoing commitment to real-world data collection will continue to drive the transformation to deep personalization of surgical devices and procedures.\u201d\n<\/p>\n

\nThe landmark COMPaSS study will evaluate spinal alignment, complications, and patient reported outcome measures for a wide variety of patients with degenerative spinal conditions.\n<\/p>\n

\nAbout Carlsmed\n<\/p>\n

\nCarlsmed\u2019s mission is to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. Carlsmed uses patient data and proprietary digital technologies to create aprevo spine fusion devices that are both patient specific and surgeon specific. For more information, visit carlsmed.com<\/a> or contact us at info@carlsmed.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nRachid Ouidja
\n
rouidja@carlsmed.com<\/a>
(760) 521-0167\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CARLSBAD, Calif.–(BUSINESS WIRE)–#NASS–Carlsmed\u00ae announced today that the first patients have been enrolled in the COMPaSS\u2122 study. COMPaSS, Clinical Outcome Measures in Personalized aprevo\u00ae Spine Surgery, is a multi-center post market prospective observational registry. The study will collect data on patients with degenerative spinal conditions and are treated surgically with Carlsmed aprevo devices and will track … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49472","6":"format-standard","7":"category-industry"},"yoast_head":"\nCOMPaSS\u2122 Personalized Spine Surgery Study Begins Enrollment - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COMPaSS\u2122 Personalized Spine Surgery Study Begins Enrollment - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CARLSBAD, Calif.–(BUSINESS WIRE)–#NASS–Carlsmed\u00ae announced today that the first patients have been enrolled in the COMPaSS\u2122 study. COMPaSS, Clinical Outcome Measures in Personalized aprevo\u00ae Spine Surgery, is a multi-center post market prospective observational registry. The study will collect data on patients with degenerative spinal conditions and are treated surgically with Carlsmed aprevo devices and will track ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-11T10:01:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221011005156\/en\/1424228\/21\/SQUARECarlsmed_logo-CMYK.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/compass-personalized-spine-surgery-study-begins-enrollment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/compass-personalized-spine-surgery-study-begins-enrollment\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"COMPaSS\u2122 Personalized Spine Surgery Study Begins Enrollment\",\"datePublished\":\"2022-10-11T10:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/compass-personalized-spine-surgery-study-begins-enrollment\\\/\"},\"wordCount\":281,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/compass-personalized-spine-surgery-study-begins-enrollment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221011005156\\\/en\\\/1424228\\\/21\\\/SQUARECarlsmed_logo-CMYK.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/compass-personalized-spine-surgery-study-begins-enrollment\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/compass-personalized-spine-surgery-study-begins-enrollment\\\/\",\"name\":\"COMPaSS\u2122 Personalized Spine Surgery Study Begins Enrollment - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/compass-personalized-spine-surgery-study-begins-enrollment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/compass-personalized-spine-surgery-study-begins-enrollment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221011005156\\\/en\\\/1424228\\\/21\\\/SQUARECarlsmed_logo-CMYK.jpg\",\"datePublished\":\"2022-10-11T10:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/compass-personalized-spine-surgery-study-begins-enrollment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/compass-personalized-spine-surgery-study-begins-enrollment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/compass-personalized-spine-surgery-study-begins-enrollment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221011005156\\\/en\\\/1424228\\\/21\\\/SQUARECarlsmed_logo-CMYK.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221011005156\\\/en\\\/1424228\\\/21\\\/SQUARECarlsmed_logo-CMYK.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/compass-personalized-spine-surgery-study-begins-enrollment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"COMPaSS\u2122 Personalized Spine Surgery Study Begins Enrollment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COMPaSS\u2122 Personalized Spine Surgery Study Begins Enrollment - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/","og_locale":"en_US","og_type":"article","og_title":"COMPaSS\u2122 Personalized Spine Surgery Study Begins Enrollment - Pharma Trend","og_description":"CARLSBAD, Calif.–(BUSINESS WIRE)–#NASS–Carlsmed\u00ae announced today that the first patients have been enrolled in the COMPaSS\u2122 study. COMPaSS, Clinical Outcome Measures in Personalized aprevo\u00ae Spine Surgery, is a multi-center post market prospective observational registry. The study will collect data on patients with degenerative spinal conditions and are treated surgically with Carlsmed aprevo devices and will track ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-11T10:01:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221011005156\/en\/1424228\/21\/SQUARECarlsmed_logo-CMYK.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"COMPaSS\u2122 Personalized Spine Surgery Study Begins Enrollment","datePublished":"2022-10-11T10:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/"},"wordCount":281,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221011005156\/en\/1424228\/21\/SQUARECarlsmed_logo-CMYK.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/","url":"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/","name":"COMPaSS\u2122 Personalized Spine Surgery Study Begins Enrollment - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221011005156\/en\/1424228\/21\/SQUARECarlsmed_logo-CMYK.jpg","datePublished":"2022-10-11T10:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221011005156\/en\/1424228\/21\/SQUARECarlsmed_logo-CMYK.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221011005156\/en\/1424228\/21\/SQUARECarlsmed_logo-CMYK.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/compass-personalized-spine-surgery-study-begins-enrollment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"COMPaSS\u2122 Personalized Spine Surgery Study Begins Enrollment"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49472"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49472\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}